Emergent BioSolutions Inc. — Director's Dealing 2022

Mar 4, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2022-03-01

Reporting Person: Fox Jennifer Lynne (EVP, Ext Aff, GC, Corp Sec)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	7250	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Options (Right to Buy)	$64.24	2026-01-10	Common Stock (1558.0)		Direct
Employee Stock Options (Right to Buy)	$61.44	2027-02-24	Common Stock (4476.0)		Direct
Employee Stock Options (Right to Buy)	$93.49	2028-02-23	Common Stock (4012.0)		Direct

Footnotes

F1: Consists of 934 shares and 6,316 unvested RSUs granted from the Emergent Stock Incentive Plan. Each RSU represents a right to receive one share of common stock. The RSUs vest in three equal installments annually on the day prior to the anniversary date of the grant.

F2: Vests in three equal installments beginning on the day prior to the anniversary date of the grant.